Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

BUY
$21.58 - $29.5 $886,053 - $1.21 Million
41,059 Added 108.14%
79,026 $2.14 Million
Q3 2023

Nov 01, 2023

BUY
$25.8 - $39.97 $819,872 - $1.27 Million
31,778 Added 513.46%
37,967 $1.13 Million
Q4 2022

Jan 31, 2023

BUY
$25.44 - $59.78 $157,448 - $369,978
6,189 New
6,189 $168,000
Q1 2021

May 17, 2021

SELL
$127.04 - $179.1 $2.57 Million - $3.62 Million
-20,237 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$99.96 - $135.93 $2.02 Million - $2.75 Million
20,237 New
20,237 $2.61 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $4.8B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Knights Of Columbus Asset Advisors LLC Portfolio

Follow Knights Of Columbus Asset Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.